The Risk-Benefit Balance in the COVID-19 “Vaccine Hesitancy” Literature: An Umbrella Review Protocol

Chaufan Claudia, Natalie Hemsing, Jennifer McDonald, Camila Heredia
{"title":"The Risk-Benefit Balance in the COVID-19 “Vaccine Hesitancy” Literature: An Umbrella Review Protocol","authors":"Chaufan Claudia, Natalie Hemsing, Jennifer McDonald, Camila Heredia","doi":"10.56098/ijvtpr.v2i2.62","DOIUrl":null,"url":null,"abstract":"Background: “Vaccine hesitancy” has been described as a major public health problem, especially in the COVID-19 era. Identified factors driving “hesitancy” include the concerns of recipients with the safety, side effects, and risk-benefit ratio of COVID-19 vaccines[1] — a proper assessment and disclosure of which are critical to the requisite process of informed consent. However, the expert literature has given little attention to the evidence informing these concerns, focusing instead on features of the recipients themselves to explain the phenomenon of so-called “hesitancy”. \nGoal: This umbrella review will expand the scope of research on “vaccine hesitancy” by examining how the safety, side effects, and risk-benefit ratio concerns of recipients of COVID-19 vaccines are addressed in the expert literature.  \nInclusion criteria: We will include systematic reviews on COVID-19 “vaccine hesitancy” that examine hesitancy in any population involved with COVID-19 vaccination decisions for themselves or as caretakers (e.g., decisions about “vaccinating” their children) to capture the broadest possible range of perspectives on the phenomenon of interest. Only completed, published, and refereed systematic reviews in English will be included. \nMethods: We will search PubMed, the Epistemonokos COVID-19 platform (COVID-19 L·OVE), and the WHO Global Research on COVID-19 Database to locate quantitative, qualitative, and mixed methods studies reviews. Reviews that meet the inclusion criteria will undergo quality assessment (AMSTAR) and data extraction. Two reviewers will independently conduct title and abstract screening and extract and synthesize the data. Disagreements will be resolved through full team discussion. Subgroup analyses will be performed to compare findings according to social indicators of target populations, country location of the first author, and other contextual factors. Thematic analysis and synthesis will be used to “transform the data” into themes by applying a deductive-inductive approach. Frequency distributions will be calculated to assess the strength of support for each theme. Findings will be presented in tabular and narrative forms to facilitate their interpretation. \nSignificance: Informed consent is a fundamental bioethical principle in medical research and practice. Insufficient attention to the concerns of vaccine recipients about these matters, compounded by a neglect to discuss the evidence-base informing these concerns, may contribute to the very problem that the COVID-19 “vaccine hesitancy” expert literature purports to address. This is especially true of an intervention based on novel technologies and intended to be delivered on a global scale. Identifying if and how the expert literature engages with these concerns is critical. \nSystematic review registration: PROSPERO CRD42022351489. \n  \n[1] Although we use the phrase “COVID-19 vaccines” throughout, we believe they should more appropriately be referred to as “COVID-19 genetic vaccines”, “COVID-19 injections”, or \"mRNA biologicals”. However, we have chosen “vaccine” with no quotation marks for better readability. For an in-depth discussion of this issue, see Rose (2021).","PeriodicalId":391540,"journal":{"name":"International Journal of Vaccine Theory, Practice, and Research","volume":"13 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Vaccine Theory, Practice, and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.56098/ijvtpr.v2i2.62","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: “Vaccine hesitancy” has been described as a major public health problem, especially in the COVID-19 era. Identified factors driving “hesitancy” include the concerns of recipients with the safety, side effects, and risk-benefit ratio of COVID-19 vaccines[1] — a proper assessment and disclosure of which are critical to the requisite process of informed consent. However, the expert literature has given little attention to the evidence informing these concerns, focusing instead on features of the recipients themselves to explain the phenomenon of so-called “hesitancy”. Goal: This umbrella review will expand the scope of research on “vaccine hesitancy” by examining how the safety, side effects, and risk-benefit ratio concerns of recipients of COVID-19 vaccines are addressed in the expert literature.  Inclusion criteria: We will include systematic reviews on COVID-19 “vaccine hesitancy” that examine hesitancy in any population involved with COVID-19 vaccination decisions for themselves or as caretakers (e.g., decisions about “vaccinating” their children) to capture the broadest possible range of perspectives on the phenomenon of interest. Only completed, published, and refereed systematic reviews in English will be included. Methods: We will search PubMed, the Epistemonokos COVID-19 platform (COVID-19 L·OVE), and the WHO Global Research on COVID-19 Database to locate quantitative, qualitative, and mixed methods studies reviews. Reviews that meet the inclusion criteria will undergo quality assessment (AMSTAR) and data extraction. Two reviewers will independently conduct title and abstract screening and extract and synthesize the data. Disagreements will be resolved through full team discussion. Subgroup analyses will be performed to compare findings according to social indicators of target populations, country location of the first author, and other contextual factors. Thematic analysis and synthesis will be used to “transform the data” into themes by applying a deductive-inductive approach. Frequency distributions will be calculated to assess the strength of support for each theme. Findings will be presented in tabular and narrative forms to facilitate their interpretation. Significance: Informed consent is a fundamental bioethical principle in medical research and practice. Insufficient attention to the concerns of vaccine recipients about these matters, compounded by a neglect to discuss the evidence-base informing these concerns, may contribute to the very problem that the COVID-19 “vaccine hesitancy” expert literature purports to address. This is especially true of an intervention based on novel technologies and intended to be delivered on a global scale. Identifying if and how the expert literature engages with these concerns is critical. Systematic review registration: PROSPERO CRD42022351489.   [1] Although we use the phrase “COVID-19 vaccines” throughout, we believe they should more appropriately be referred to as “COVID-19 genetic vaccines”, “COVID-19 injections”, or "mRNA biologicals”. However, we have chosen “vaccine” with no quotation marks for better readability. For an in-depth discussion of this issue, see Rose (2021).
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
COVID-19“疫苗犹豫”文献中的风险-收益平衡:一项总括性审查方案
背景:“疫苗犹豫”已被描述为一个重大的公共卫生问题,特别是在COVID-19时代。已确定的导致“犹豫”的因素包括接受者对COVID-19疫苗的安全性、副作用和风险效益比的担忧[1],对这些因素进行适当评估和披露对知情同意的必要过程至关重要。然而,专家文献很少关注这些担忧的证据,而是关注接受者自身的特征来解释所谓的“犹豫”现象。目的:本总括性综述将通过研究专家文献如何解决COVID-19疫苗接种者的安全性、副作用和风险-效益比问题,扩大“疫苗犹豫”的研究范围。纳入标准:我们将纳入关于COVID-19“疫苗犹豫”的系统评价,检查自己或作为看护人参与COVID-19疫苗接种决策的任何人群的犹豫(例如,决定是否为子女“接种疫苗”),以获取有关感兴趣现象的尽可能广泛的观点。只有完成的、发表的和经过评审的英文系统综述才会被包括在内。方法:检索PubMed、Epistemonokos COVID-19平台(COVID-19 L·OVE)和WHO全球COVID-19研究数据库,查找定量、定性和混合方法研究综述。符合纳入标准的审查将进行质量评估(AMSTAR)和数据提取。两名审稿人将独立进行标题和摘要筛选,并对数据进行提取和综合。分歧将通过全队讨论来解决。将进行分组分析,根据目标人群的社会指标、第一作者所在国家和其他背景因素比较调查结果。主题分析和综合将通过运用演绎-归纳方法将数据“转化”为主题。将计算频率分布,以评估对每个主题的支持力度。调查结果将以表格和叙述形式提出,以方便解释。意义:知情同意是医学研究和实践中的一项基本生物伦理原则。对疫苗接种者对这些问题的担忧关注不足,再加上忽视讨论告知这些担忧的证据基础,可能会导致专家文献声称要解决的COVID-19“疫苗犹豫”问题。基于新技术的干预尤其如此,并打算在全球范围内实施。确定专家文献是否以及如何涉及这些问题是至关重要的。系统评价注册:PROSPERO CRD42022351489。[1]尽管我们自始至终使用“COVID-19疫苗”一词,但我们认为,将其称为“COVID-19基因疫苗”、“COVID-19注射剂”或“mRNA生物制品”更为恰当。但是,为了更好的可读性,我们选择了没有引号的“vaccine”。关于这个问题的深入讨论,请参见Rose(2021)。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Real-Time Self-Assembly of Stereomicroscopically Visible Artificial Constructions in Incubated Specimens of mRNA Products Mainly from Pfizer and Moderna: A Comprehensive Longitudinal Study Adjuvant Activity and Toxicological Risks of Lipid Nanoparticles Contained in the COVID‑19 “mRNA Vaccines” Perceived Experience in Social Circles with COVID-19 Injections and COVID-19 “Vaccine” Mandates: An Online Survey of the United States Population How Many Deaths Can Statistically Be Attributed to Anti-SARS-CoV-2 Injections? An Analysis of German Health Data from 2021 The Canaries in the Human DNA Mine
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1